mutations and complicated kar yotype. It follows a linear evolution from the CLL clone with the recurrent acquisition of CDKN2ANot all sufferers with CLL require therapy. Despite all the latest developments, the iwCLL nevertheless suggests watchful observation for people with asymptomatic ailment.86 This recommendation is based on at the least two